{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04482374",
            "orgStudyIdInfo": {
                "id": "19-2109"
            },
            "organization": {
                "fullName": "University of Colorado, Denver",
                "class": "OTHER"
            },
            "briefTitle": "Puberty Suppression and Cardiometabolic Health",
            "officialTitle": "Effects of Puberty and Pubertal Suppression on Insulin Sensitivity, Metabolic Rate and Vascular Health",
            "therapeuticArea": [
                "Other"
            ],
            "study": "puberty-suppression-and-cardiometabolic-health"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-04",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2020-08-10",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-07-31",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-07-31",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2020-06-30",
            "studyFirstSubmitQcDate": "2020-07-17",
            "studyFirstPostDateStruct": {
                "date": "2020-07-22",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-04-30",
            "lastUpdatePostDateStruct": {
                "date": "2024-05-02",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "University of Colorado, Denver",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This observational study will evaluate the effect of puberty suppression on insulin sensitivity, metabolic rate and vascular health among transgender female youth at baseline and 6 months after initiation of a gondoatropin releasing hormone agonist compared to matched cisgender male controls."
        },
        "conditionsModule": {
            "conditions": [
                "Transgenderism",
                "Insulin Sensitivity/Resistance",
                "Endothelial Dysfunction",
                "Vascular Stiffness"
            ]
        },
        "designModule": {
            "studyType": "OBSERVATIONAL",
            "patientRegistry": false,
            "designInfo": {
                "observationalModel": "COHORT",
                "timePerspective": "PROSPECTIVE"
            },
            "bioSpec": {
                "retention": "SAMPLES_WITHOUT_DNA",
                "description": "Blood"
            },
            "enrollmentInfo": {
                "count": 30,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Transgender females",
                    "description": "Transgender females who plan to start a gonadotropin releasing hormone agonist clinically in the next 2 months"
                },
                {
                    "label": "Cisgender males",
                    "description": "Cisgender male controls"
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Change in insulin sensitivity",
                    "description": "Insulin sensitivity assessed by the oral minimal model",
                    "timeFrame": "Baseline, 6 months"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Change in body composition (fat mass, fat-free mass)",
                    "description": "Body composition measured by DXA",
                    "timeFrame": "Baseline, 6 months"
                },
                {
                    "measure": "Change in resting metabolic rate",
                    "description": "Resting metabolic rate assessed by indirect calorimetry",
                    "timeFrame": "Baseline, 6 months"
                },
                {
                    "measure": "Change in endothelial function",
                    "description": "Endothelial function assessed by brachial artery flow mediated dilation",
                    "timeFrame": "Baseline, 6 months"
                },
                {
                    "measure": "Change in large elastic artery stiffness",
                    "description": "Large elastic assessed by carotid ultrasound",
                    "timeFrame": "Baseline, 6 months"
                },
                {
                    "measure": "Change in cerebrovascular function",
                    "description": "Middle cerebral artery blood flow assessed using bilateral transcranial Doppler",
                    "timeFrame": "Baseline, 6 months"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Identify as a transgender female or cisgender male\n* Age 9-14 years at the time of enrollment\n* Tanner Stage 2-3 baseline pubertal development\n* Plan to start gonadotropin releasing hormone analogue clinically in \\< 2 months (for transgender females only)\n\nExclusion Criteria:\n\n* Cognitive, psychiatric, or physical impairment resulting in inability to tolerate the study procedures\n* Type 1 or 2 diabetes (by medical history)\n* On any medications that affect insulin sensitivity (e.g. metformin, antipsychotics)\n* Hypertension (resting BP \u2265 140/90 mm/Hg)\n* Weight \\> 400 lbs\n* On estrogen- or progesterone-containing medications at baseline\n* \\>3 hours of moderate-to-vigorous physical activity on the 3DPAR at the screening visit",
            "sex": "MALE",
            "genderBased": true,
            "genderDescription": "Transgender females, cisgender males",
            "minimumAge": "9 Years",
            "maximumAge": "14 Years",
            "stdAges": [
                "CHILD"
            ],
            "studyPopulation": "15 transgender females (male sex assigned at birth, female gender identity) and 15 cisgender males",
            "samplingMethod": "NON_PROBABILITY_SAMPLE"
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Natalie J Nokoff, MD, MSCS",
                    "role": "CONTACT",
                    "phone": "720-777-6128",
                    "email": "natalie.nokoff@childrenscolorado.org"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Natalie J Nokoff, MD, MSCS",
                    "affiliation": "University of Colorado, Denver",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "University of Colorado Anschutz Medical Campus",
                    "status": "RECRUITING",
                    "city": "Aurora",
                    "state": "Colorado",
                    "zip": "80045",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Natalie Nokoff, MD, MSCS",
                            "role": "CONTACT",
                            "phone": "720-777-3607",
                            "email": "Natalie.Nokoff@childrenscolorado.org"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.72943,
                        "lon": -104.83192
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "UNDECIDED"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000007333",
                    "term": "Insulin Resistance"
                },
                {
                    "id": "D000006967",
                    "term": "Hypersensitivity"
                }
            ],
            "ancestors": [
                {
                    "id": "D000007154",
                    "term": "Immune System Diseases"
                },
                {
                    "id": "D000006946",
                    "term": "Hyperinsulinism"
                },
                {
                    "id": "D000044882",
                    "term": "Glucose Metabolism Disorders"
                },
                {
                    "id": "D000008659",
                    "term": "Metabolic Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M10018",
                    "name": "Hypersensitivity",
                    "asFound": "Sensitivity",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10370",
                    "name": "Insulin Resistance",
                    "asFound": "Insulin Sensitivity",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10200",
                    "name": "Immune System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M9997",
                    "name": "Hyperinsulinism",
                    "relevance": "LOW"
                },
                {
                    "id": "M11639",
                    "name": "Metabolic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M25403",
                    "name": "Glucose Metabolism Disorders",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC20",
                    "name": "Immune System Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC18",
                    "name": "Nutritional and Metabolic Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M9789",
                    "name": "Hormones",
                    "relevance": "LOW"
                },
                {
                    "id": "M10365",
                    "name": "Insulin",
                    "relevance": "LOW"
                },
                {
                    "id": "M173166",
                    "name": "Insulin, Globin Zinc",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "Hypo",
                    "name": "Hypoglycemic Agents"
                }
            ]
        }
    },
    "hasResults": false
}